Pre-treatment with Irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation
Open Access
- 22 March 2006
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 27 (17) , 2062-2068
- https://doi.org/10.1093/eurheartj/ehl190
Abstract
Aims Left atrial (LA) stunning, the transient impairment of LA function, is responsible for an increased thrombo-embolic risk after cardioversion of atrial fibrillation (AF). Angiotensin receptor blockers (ARBs) attenuate atrial remodelling in AF and could theoretically influence LA stunning. We studied the effect of Irbesartan on LA stunning.Keywords
This publication has 0 references indexed in Scilit: